Prostate cancer becomes UK’s most common cancer amid calls for screening
Independent - 28-Jan-2025Rising diagnoses spark debate over national testing and healthcare inequalities
Join the club for FREE to access the whole archive and other member benefits.
Rising diagnoses spark debate over national testing and healthcare inequalities
Fitness and muscle strength linked to better survival rates
It offers a faster, less invasive way to improve early diagnosis
Calcium may protect by neutralizing harmful colon acids
New cell discovery could transform immunotherapy outcomes
The new method uses radiotracers to make cancer cells visible
Increased screening and awareness drive advances, but challenges in treatment delays remain
It achieved 86.3% accuracy, reducing misdiagnoses and referrals
This could lead to safer, non-destructive cancer treatments with fewer side effects
Revolutionary gene therapy disables cancer cells’ mitochondria, sparing healthy tissue
It identifies subtle blood changes and distinguishes cancer subtypes
UCLA unveils viscoelastic antigen mimics to boost immunity and fight cancer
Therapies targeting senescence cells show promise for controlling cancer progression
Targeted drug delivery and immune boost for personalized cancer therapy
Experts believe expanding this initiative could help save more lives
In trials on mice, the drug reduced tumors, promising new cancer treatments
New tech at NHS trusts speeds up cancer detection in high-risk areas
Tailored drug dosing could reduce harmful reactions for cancer patients
Unravelling tumour dynamics to enhance cancer treatment
A new trial offers hope for glioblastoma patients as innovative treatment yields significant results
Study suggests a healthy diet may reduce the risk of cancer advancing during active surveillance
The technology extends survival for some patients by 3.3 months
New funding accelerates the development of a novel neutrophil-based solid tumour treatment
Innovative £120 test could identify 12 common cancers, revolutionizing patient care and saving lives
Clinical trial shows treatment extends survival for patients with advanced lung cancer by over 40%